Stroke Spasticity Management: 17 Treatments Ranked From Worst to Best

There's a lot of conflicting information out there about stroke spasticity management. So instead of opinions, let's go straight to the research — specifically the GRADE methodology used by the Canadian Stroke Best Practice Guidelines, one of the most rigorously evidence-graded stroke rehabilitation resources available.

Every treatment below is ranked based on what the science actually says about its effectiveness for spasticity after stroke. Not what feels intuitive. Not what's commonly prescribed. What the research shows.

https://www.youtube.com/watch?v=-NXjwbaUNwo

How These Stroke Spasticity Management Tiers Work

These rankings follow GRADE methodology — the system researchers and major clinical organizations use to evaluate whether a treatment actually works. It accounts for study quality, patient numbers, and consistency of results.

S Tier — Strong recommendation, high quality evidence, explicit first-line designation. Very few treatments reach this level.

A Tier — GRADE A evidence from multiple randomized controlled trials analyzed together. Rigorous and consistent.

B Tier — Real clinical signal, solid evidence base, hasn't fully cleared the GRADE A bar yet.

Emerging Tier — Promising early results, no completed RCTs yet. Science is still catching up.

C Tier — Limited spasticity-specific evidence. Reasonable add-on, not a primary approach.

D Tier — Has a supporting role only.

F Tier — GRADE A evidence that it does NOT work as a standalone. This isn't weak evidence — this is the research coming back with a clear answer. D and F are not the same thing.

One note before getting into it: a few treatments have their strongest evidence in motor recovery, not spasticity specifically. That's flagged where relevant.

C Tier

Kinesio Taping

The colorful tape applied along the forearm or hand is common in stroke rehab and the clinical rationale is real — tape provides sensory input to the skin and underlying tissue that can temporarily influence muscle tone.

The problem is the spasticity-specific research. Studies are small, follow-up periods are short, and results are inconsistent. It's not that it does nothing — it's that there isn't strong enough evidence to say it meaningfully moves the needle on stroke spasticity management on its own.

Verdict: Reasonable add-on if already part of your plan. Not something to build your program around.

Dry Needling and Acupuncture

Grouped together because the delivery method is similar, though the clinical rationale differs.

Dry needling actually has GRADE A evidence — but with a significant caveat. That evidence is specifically for lower extremity spasticity, and the effect only held up at one-week follow-up. At four weeks, results weren't significant. For upper extremity spasticity, the evidence isn't there.

Acupuncture tells a similar story. Its stronger evidence is actually in motor recovery — which puts it higher on a motor recovery tier list. For spasticity specifically, particularly upper extremity, the evidence doesn't hold up under scrutiny.

Verdict: C tier for stroke spasticity management. Potentially higher on a motor recovery list.

D Tier

Oral Medications (Baclofen, Tizanidine, Diazepam)

These get prescribed frequently after stroke and the mechanism is real — they do reduce tone. But when put through rigorous GRADE-level analysis, they don't reach the bar for strong evidence in stroke spasticity management. And the side effect profile is significant: sedation, fatigue, and generalized muscle weakness — the last of which matters considerably if the goal is to actually use the arm.

Verdict: Supporting role only. If your doctor prescribed these, that's a conversation between you and your physician. But if this is your primary spasticity strategy, the evidence says it shouldn't be.

Resting Hand Splint

If you've been through stroke rehab, there's a good chance you own one of these. Here's what's important: the Canadian Stroke Guidelines don't just say the evidence is weak — they give a strong recommendation against routine use as a standalone spasticity intervention. That's a specific statement based on sufficient research.

This does not mean splints have no role. They can help with positioning, comfort, and preventing contracture — all legitimate reasons. But if you're wearing one primarily to reduce long-term spasticity, the research doesn't support that expectation.

Verdict: Supporting role only. Not your primary stroke spasticity management approach.

B Tier

Serial Casting

A cast is applied to hold the joint at end range — typically wrist or ankle — and changed every few days as the tissue lengthens. The evidence is stronger than the resting splint, particularly for contracture prevention and range of motion gains.

The important distinction: serial casting addresses the mechanical side of tightness. Spasticity — the nervous system signal driving the tightness — is a separate issue. These are related problems but not the same problem.

Verdict: Solid clinical tool with a real evidence base. Know which problem you're solving with it.

Dynamic Splinting

Different from the static resting splint — and that distinction matters. Where a static splint holds one fixed position, a dynamic splint uses spring tension or elastic resistance to apply a low-load prolonged stretch through range of motion.

The Canadian Guidelines specifically mention dynamic splinting as an adjunct to Botox — meaning the evidence supports it as a tool that works alongside other interventions, particularly after tone has already been reduced. It's not a strong standalone — it's effective within a broader plan.

Verdict: Better evidence and mechanism than the static splint. Most effective as part of a combined approach.

Phenol and Alcohol Neurolysis

Less commonly known but clinically established. A chemical agent is injected around a nerve to interrupt the signal driving spasticity — similar in concept to Botox but targeting the nerve itself rather than the neuromuscular junction.

Why isn't it used more? It requires significant technical expertise, the side effect profile is more significant than Botox (risk of painful abnormal sensations if not precisely placed), and Botox has a cleaner evidence base for most cases. Neurolysis tends to appear clinically when Botox isn't practical — large muscle groups exceeding safe Botox dose limits, cost barriers, or Botox resistance over time.

Verdict: Real clinical tool with a legitimate evidence base. Not first-line for most people.

NMES and FES (Neuromuscular and Functional Electrical Stimulation)

Electrodes placed on the skin deliver electrical current that triggers actual muscle contraction — not just sensory stimulation. The evidence for NMES and FES on spasticity specifically is moderate: real signal, clinically used, but hasn't cleared GRADE A for spasticity reduction.

Important distinction: for motor recovery, the evidence is significantly stronger. NMES and FES rank much higher on a motor recovery tier list. The technology is sound — it's just that spasticity reduction and motor recovery are different primary outcomes.

Verdict: B tier for stroke spasticity management. Considerably higher on the motor recovery list.

A Tier

Everything from here forward has multiple randomized controlled trials analyzed together in systematic reviews behind it. The bar is meaningfully higher.

TENS (Transcutaneous Electrical Nerve Stimulation)

This one surprises people — especially those who know TENS primarily as a pain relief tool. Unlike NMES, TENS works at the sensory level: no muscle contraction, just sensory input modulating the nervous system's output.

High-frequency TENS (around 100 Hz) activates inhibitory pathways in the spinal cord — essentially sending a calming signal that dials back the overactive motor output driving spasticity. That mechanism is exactly why it lands here.

Protocol details matter: the evidence supports sessions of at least 30-60 minutes, 5 days a week, for at least four weeks. This isn't a one-session fix. Also worth noting: the evidence is stronger for lower extremity than upper extremity spasticity.

Verdict: Strong evidence, accessible technology, clear mechanism. A tier.

Vibration Therapy

Two variations — whole body vibration and localized muscle vibration — both with GRADE A evidence and similar mechanisms. Vibration activates muscle spindle receptors that send organized sensory input to the spinal cord and brain, modulating the overactive signals driving spasticity.

Localized muscle vibration: A vibrating device applied directly to the target muscle or tendon. Upper extremity data — elbow and wrist specifically — is solid. More accessible than whole body vibration and applicable at home with the right device.

Whole body vibration: Standing on a vibrating platform also has GRADE A evidence, but with an important caveat — the research supports it specifically in early and subacute stages of recovery.

Verdict: Both land in A tier. Know which version applies to your stage and situation.

Repetitive Peripheral Magnetic Stimulation (rPMS)

Magnetic pulses delivered directly to a muscle or nerve to calm down the overactive signals driving spasticity. Same core goal as other A tier tools — change the input the nervous system is receiving to change the output. Different delivery method.

The honest caveat: this isn't widely available in most clinics yet. The research supports it, but accessibility is limited. Worth asking about if working with a physiatrist or rehabilitation specialist.

Verdict: Strong evidence, limited accessibility for now. A tier.

Intrathecal Baclofen

A pump surgically implanted under the skin delivers baclofen directly into the fluid surrounding the spinal cord. Because it bypasses the bloodstream, it works at much lower doses with significantly fewer side effects than oral baclofen.

The evidence is solid. But this is reserved for severe, widespread spasticity that hasn't responded to other treatments. It's a specialist conversation, a surgical procedure, and a significant long-term commitment.

Verdict: Strong evidence, narrow population. A tier — but only relevant for severe cases that haven't responded to other approaches.

Non-Invasive Brain Stimulation (rTMS and tDCS)

Two variations — repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS). After stroke, one side of the brain becomes overactive and essentially drowns out the affected side. Both tools work by rebalancing that.

rTMS uses magnetic pulses to calm the overactive hemisphere. tDCS uses a very mild electrical current — most people barely feel it — to achieve the same result. The outcome: a nervous system more receptive to rehabilitation. Less noise, more signal.

What makes these notable in the context of stroke spasticity management is that most other A tier tools work at the muscle or nerve level. These work at the brain level — a fundamentally different approach with strong upper extremity spasticity evidence.

Verdict: Clinical setting required. A tier for stroke spasticity management.

Extracorporeal Shock Wave Therapy (ESWT)

One of the strongest evidence bases on this entire list — 42 randomized controlled trials and close to 2,000 patients in the research. A device delivers focused pressure waves directly into the spastic muscle, breaking down tissue stiffness and influencing the nerve signals driving tone.

What makes ESWT stand out is duration of effect. Studies show meaningful reductions in spasticity lasting up to 12 weeks from just a handful of sessions — a longer window than most other tools on this list. The version with the strongest evidence is radial ESWT, with at least two sessions needed for meaningful results. Available at some rehab clinics and sports medicine facilities.

Verdict: One of the most underused tools on this entire list given how strong the evidence is. A tier.

Emerging Tier

Cryoneurolysis

A cold probe placed next to a nerve temporarily interrupts the signal driving spasticity. The nerve regrows over weeks to months — but in that window, tone is reduced and the arm becomes more manageable. Same principle as Botox: buy a window of reduced tone and use it strategically with rehab.

The reason it's not in A or S tier is straightforward — no completed randomized controlled trials yet. Current evidence is case reports and case series. Major trials are being designed now with completion estimated around 2028.

That's not a knock on the treatment. It's honesty about where the evidence is. Early results are genuinely promising — this one is worth watching closely over the next few years.

Verdict: Emerging tier. Keep an eye on this one.

F Tier

Passive Stretching Alone

If you were handed a home program at discharge, there's a good chance it had stretching in it. And if you're like most survivors — you've been doing it faithfully. That commitment is real and it matters.

But here's what the research says.

The Canadian Stroke Guidelines — after reviewing multiple randomized controlled trials — found GRADE A evidence that passive stretching alone did not significantly improve spasticity, joint mobility, activity limitations, or pain compared to doing nothing at all.

F tier is not weak evidence. F tier means the research studied this rigorously and came back with a clear answer: it doesn't work for stroke spasticity management when used alone.

One critical clarification: this is specifically about stretching as a standalone spasticity intervention. Stretching as part of a combined program, for comfort, or to maintain range of motion is a different conversation. The research isn't saying never stretch. It's saying stretching alone as your primary spasticity strategy doesn't work.

Verdict: F tier as a standalone spasticity treatment. Still has a role within a broader program.

S Tier

Botulinum Toxin A (Botox)

Only one treatment made it to S tier — and it's not close.

The Canadian Stroke Guidelines give Botox a Strong recommendation with High quality evidence — the highest rating they issue. It's the only treatment on this entire list with an explicit first-line designation, meaning the guidelines specifically say to use it over other options for focal spasticity. Decades of randomized controlled trials, systematic reviews, and real-world clinical outcomes all point in the same direction.

For tone reduction in stroke spasticity management, nothing on this list touches it.

Why does Botox sometimes feel like it didn't work?

Most of the time when Botox doesn't work, it's not the Botox — it's the delivery. The injection done without ultrasound guidance so the toxin doesn't land precisely where the problem is. Only one muscle injected when three are driving the tone. Dosing too conservative to make a meaningful difference. Any one of those things and the person feels nothing — and concludes Botox is overhyped.

If that's been your experience: find a physiatrist or movement disorder specialist who uses ultrasound guidance. Ask specifically which muscles they plan to inject and why. And ask what the rehab plan looks like afterward.

The most important thing about Botox:

Botox reduces tone. It does not recover function on its own.

What it does is buy you a window — typically three to four months — where the nervous system is more receptive, the muscle is more manageable, and rehab can actually get traction. What you do inside that window is everything. Botox without targeted rehab is a missed opportunity.

Verdict: S tier. But only S tier if you use it right.

How to Use This Information

Not every treatment on this list is appropriate for every stage of recovery. The right stroke spasticity management approach for someone three months post-stroke looks different from someone three years out.

Start by knowing your stage. If you're not sure where you are in recovery, the free Hand Recovery Stage Quiz identifies your exact stage and gives you one specific next step — takes about two minutes.

👉 [Take the free Hand Recovery Stage Quiz here]

Then have an informed conversation with your care team. Ask your neurologist or physiatrist specifically about A and S tier options — particularly Botox for focal spasticity and ESWT if you haven't heard it mentioned yet.

If you've already tried multiple approaches and aren't seeing progress, that's not a treatment problem — it's a strategy problem. That's exactly what a one-on-one strategy call is for.

👉 [Book a free Stroke Recovery Strategy Call here]

Want to understand why passive stretching fails for spasticity — and what to do instead? Read this next: [STOP Stretching to Fix Spasticity After Stroke — Do This Instead]